Cargando…

Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations

Anaplastic lymphoma kinase (ALK) is a tyrosine kinase with genomic and expression changes in many solid tumors. ALK inhibition is the first-line therapy for lung cancers with ALK alterations, and an effective therapy in other tumor types, but has not been well-studied in prostate cancer. Here, we ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Radhika A., Coleman, Ilsa, Roudier, Martine P., Konnick, Eric Q., Hanratty, Brian, Dumpit, Ruth, Lucas, Jared M., Ang, Lisa S., Low, Jin-Yih, Tretiakova, Maria S., Ha, Gavin, Lee, John K., True, Lawrence D., De Marzo, Angelo M., Nelson, Peter S., Morrissey, Colm, Pritchard, Colin C., Haffner, Michael C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635400/ https://www.ncbi.nlm.nih.gov/pubmed/36337169 http://dx.doi.org/10.1158/2767-9764.CRC-21-0156

Ejemplares similares

Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
por: De Sarkar, Navonil, et al.
Publicado: (2021)

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022)

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer
por: Sayar, Erolcan, et al.
Publicado: (2023)

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
por: Nghiem, Belinda, et al.
Publicado: (2016)

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
por: Brady, Lauren, et al.
Publicado: (2021)

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
por: Nguyen, Holly M., et al.
Publicado: (2017)

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
por: Bhatia, Vipul, et al.
Publicado: (2023)

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity
por: Jia, Deyong, et al.
Publicado: (2022)

Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
por: Konnick, Eric Q., et al.
Publicado: (2016)

Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016)

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
por: De Sarkar, Navonil, et al.
Publicado: (2023)

Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer
por: Kumar, Akash, et al.
Publicado: (2016)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
por: Zhang, Ailin, et al.
Publicado: (2023)

Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
por: Agarwal, Supreet, et al.
Publicado: (2023)

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2021)

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
por: Labrecque, Mark P., et al.
Publicado: (2021)

De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-Myc
por: Kwon, Oh-Joon, et al.
Publicado: (2020)

The regulatory landscape of precision oncology laboratory medicine in the United States – Perspective on the past 5 years and considerations for future regulation
por: Konnick, Eric Q.
Publicado: (2020)

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
por: Pritchard, Colin C., et al.
Publicado: (2014)

Single cell transcriptomic analysis of prostate cancer cells
por: Welty, Christopher J, et al.
Publicado: (2013)

Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy
por: Ruppender, Nazanin, et al.
Publicado: (2015)

Genetic background influences murine prostate gene expression: implications for cancer phenotypes
por: Bianchi-Frias, Daniella, et al.
Publicado: (2007)

Prostate cancer cell phenotypes based on AGR2 and CD10 expression
por: Ho, Melissa E., et al.
Publicado: (2013)

Anaplastic supratentorial cortical ependymoma presenting as a butterfly lesion
por: Ng, David W.K., et al.
Publicado: (2012)

Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts
por: Richards, Gavin H. C., et al.
Publicado: (2022)

Procedure Planning: Anatomical Determinants of Strategy
por: Hanratty, Colm, et al.
Publicado: (2014)

Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
por: Chéry, Lisly, et al.
Publicado: (2014)

Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
por: Yegnasubramanian, Srinivasan, et al.
Publicado: (2006)

DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance
por: Huber, Roland M., et al.
Publicado: (2014)

Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
por: Takiar, Radhika, et al.
Publicado: (2023)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
por: Coleman, Daniel J., et al.
Publicado: (2020)

SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer
por: Liao, Sheng-You, et al.
Publicado: (2023)

Multiplexed functional genomic analysis of 5’ untranslated region mutations across the spectrum of prostate cancer
por: Lim, Yiting, et al.
Publicado: (2021)

ALK-positive anaplastic large cell lymphoma in adults
por: Gromowsky, Matthew J, et al.
Publicado: (2023)

Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate
por: Abbott, Denise E, et al.
Publicado: (2003)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Anaplastic Sarcoma of the Kidney
por: Labanaris, Apostolos P., et al.
Publicado: (2009)

Mediastinal Anaplastic Ependymoma
por: Fauziah, Dyah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etb5k800idvejes8sqmlreik0b